- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06593470
Mindfulness-basert forebygging av stoffbruk (Minds-Up) (MINDS-UP)
Mindfulness-basert forebygging av stoffbruk (Minds-Up): En randomisert kontrollert studie
The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The aims of the study are:
Aim 1: Determine feasibility and acceptability of MINDS-UP as a preventive intervention via a) retention, b) attendance, c) teacher-rated participation, d) student-rated participation, e) homework completion, and f) acceptability.
Aim 2: Evaluate neuropsychological mechanisms (target engagement) of MINDS-UP.
Aim 3 (Exploratory): Assess preliminary efficacy of MINDS-UP on substance use initiation (SUI).
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: David C Saunders, MD, PhD
- Telefonnummer: 914-409-6807
- E-post: david.saunders@nyspi.columbia.edu
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Youth is ages 10-14 years on the day of screening [i.e., does not turn 15 before or on the day of screening]
- Youth has access to a smartphone, tablet, or computer with Wi-Fi
- Youth and parent are English-speaking
Exclusion Criteria:
1. The youth has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Sport: Prevention Plus Wellness (PPW)
Sport: Prevention Plus Wellness (PPW) is a brief, evidence-based substance use prevention program for youth. PPW consists of a single self-administered 45-minute session that is interactive and intended for use by youth in the home setting. It involves screening youth to increase awareness of their current health behaviors; motivational enhancement for change; and establishing a behavior goal plan. |
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45 minute self-administered online course.
Andre navn:
|
|
Eksperimentell: PPW + MINDS-UP
MINDS-UP consists of 4 x 60-minute sessions, once weekly over 4 weeks. MINDS-UP will be delivered to participants remotely, in a 1:1 setting, taught by the meditation teachers that will be hired and trained by Dr. Saunders. Additionally, participants will be provided audio files of 5-10-minute guided meditation practices, led by Dr. Saunders, as homework. Participants randomized to MINDS-UP will also complete PPW, a 45 minute, self-administered course. |
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45 minute self-administered online course.
Andre navn:
MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Retention
Tidsramme: Completion of Study (up to 36 months)
|
Percent of participants who completed all study procedures among those who were randomized |
Completion of Study (up to 36 months)
|
|
Attendance
Tidsramme: Completion of Study (up to 36 months)
|
Percent of scheduled sessions that were completed by the participant. |
Completion of Study (up to 36 months)
|
|
Teacher Rated Participation
Tidsramme: Completion of Study (up to 36 months)
|
Research Assessment Package for Schools - Teacher Rated |
Completion of Study (up to 36 months)
|
|
Student-Rated Participation
Tidsramme: Completion of Study (up to 36 months)
|
Research Assessment Package for Schools - Student Engagement |
Completion of Study (up to 36 months)
|
|
Homework Completion
Tidsramme: Completion of Study (up to 36 months)
|
Percentage of assigned homeworks that were completed by the participant. |
Completion of Study (up to 36 months)
|
|
Acceptability
Tidsramme: Completion of Study (up to 36 months)
|
Acceptability of Intervention Measure |
Completion of Study (up to 36 months)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Total Problems (parent-report)
Tidsramme: 4-8 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 98 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems |
4-8 weeks, 6 months, and 12 months
|
|
ADHD Symptoms
Tidsramme: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the ADHD Rating Scale, an 18-item parent-report assessment that measures adolescent behaviors related to ADHD (inattentiveness, hyperactivity). |
4-6 weeks, 6 months, and 12 months
|
|
Suicidal Thoughts/Behaviors
Tidsramme: 4-6 weeks, 6 months, 12 months
|
The C-SSRS is a gold-standard assessment tool for suicide risk. This tool will be administered at every visit. |
4-6 weeks, 6 months, 12 months
|
|
Alcohol sipping
Tidsramme: 4-6 weeks, 6 months, and 12 months
|
Low-level and early alcohol use as characterized by the iSay Sipping Inventory. This survey characterizes low level and first/early alcohol use, including age at first sip, whether that drink was completed, and behaviors after the first sip. |
4-6 weeks, 6 months, and 12 months
|
|
Tobacco Use
Tidsramme: 4-6 weeks, 6 months, and 12 months
|
Tobacco use as measured by Tobacco Low Level Use Measure. This is a short tool that measures number of times used, type of tobacco/nicotine used, duration of use, and frequency of use. |
4-6 weeks, 6 months, and 12 months
|
|
Cannabis Use
Tidsramme: 4-6 weeks, 6 months, and 12 months
|
Cannabis use as measured by the Marijuana Low-Level Use Measure, a short tool that measures early/first use of cannabis. |
4-6 weeks, 6 months, and 12 months
|
|
Total Problems (adolescent report)
Tidsramme: 4-6 weeks, 6 months, 12 months
|
The Youth Self Report (YSR) is the self-report adolescent version of the Child Behavior Checklist, and is used to assess emotional and behavioral problems in children and adolescents. |
4-6 weeks, 6 months, 12 months
|
|
Mindfulness
Tidsramme: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the Child and Adolescent Mindfulness Measure (CAMM); the CAMM is a 10-item measure of self-reported mindfulness; scores range from 0 to 40, with higher scores indicating higher mindfulness |
4-6 weeks, 6 months, and 12 months
|
|
Anxiety and Depression
Tidsramme: 4-6 weeks, 6 months, and 12 months
|
Pre-assessment to post-assessment (and 6 and 12 month-follow-up) difference in score on the Revised Childhood Anxiety and Depression scale, a 47-item self-report scale that assesses childhood/adolescent anxiety and depression symptoms across six sub-domains. |
4-6 weeks, 6 months, and 12 months
|
|
Perceived Tolerance of Use
Tidsramme: baseline
|
The Perceived Tolerance of Use is a tool that assesses peer tolerance of use of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is a tool that is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use. |
baseline
|
|
Perceived Harm of Substance Use
Tidsramme: baseline
|
The Perceived Harm of Substance Use tool assesses perceived harm of substance use (of substances that a participant has heard of, meaning the number of items is variable). It is used in the ABCD study and the Monitoring the Future Study, the two most comprehensive studies of adolescent substance use. |
baseline
|
|
Beliefs About Alcohol Effects
Tidsramme: baseline
|
The Brief Comprehensive Effects of Alcohol Questionnaire is a 15-item self-report version of the Comprehensive Effects of Alcohol Questionnaire that is used by the ABCD study to assess an adolescent's expectations of using alcohol. |
baseline
|
|
Beliefs About Smoking Effects
Tidsramme: baseline
|
The Adolescent Smoking Consequences Questionnaire (ASCQ) is a 30-item self-report instrument used to assess outcome expectancies of cigarette smoking among adolescents. |
baseline
|
|
Beliefs About Cannabis Effects
Tidsramme: baseline
|
Brief -Marijuana Effect Expectancies Questionnaire (MEEQ-B) is a 6-item self-report assessment of an adolescent's expected effect of marijuana. |
baseline
|
|
Risk and Protective Factors
Tidsramme: Baseline
|
The Community Risk and Protective Factors Survey is a 24-item parent-report tool to assess adolescent's experience of exposure to substance use risk and protective factors in the community. |
Baseline
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- #Pro00076319
- K12DA000357 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .